ID
40953
Description
The primary focus of this first time in human (FTIH) study was to evaluate the safety and tolerability of GSK1292263 and to estimate GSK1292263 pharmacokinetic (PK) parameters and pharmacodynamic (PD) effects in healthy volunteers. Subject: FTIH, oral, safety, tolerability, pharmacokinetics, glucose, pharmacodynamics, male, female, gastric emptying Indication Studied: Type 2 Diabetes Mellitus Study ID: 111596 Clinical Study ID: 111596 Study Title: A study in healthy volunteers of single doses of orally administered GSK1292263 to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of the compound alone and when co-administered with sitagliptin Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00783549 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GSK1292263, Sitagliptin Trade Name: N/A Study Indication: Dyslipidaemias
Keywords
Versions (2)
- 4/25/20 4/25/20 -
- 6/7/20 6/7/20 -
Copyright Holder
GlaxoSmithKline
Uploaded on
June 7, 2020
DOI
To request one please log in.
License
Creative Commons BY-NC 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
A study in healthy volunteers of single doses of orally administered GSK1292263 to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of the compound alone and when co-administered with sitagliptin
Medical conditions (Liver MEDHX), Liver Event 5-DF
- StudyEvent: ODM
Description
Drug related liver disease conditions (All drugs including Investigational Product)
Alias
- UMLS CUI-1
- C0023895
- UMLS CUI-2
- C0277579
Description
Other liver disease conditions
Description
[hidden] Item is not required
Data type
text
Alias
- UMLS CUI [1]
- C2348184
Description
Specific Condition
Data type
text
Alias
- UMLS CUI [1,1]
- C0012634
- UMLS CUI [1,2]
- C2348235
Description
[hidden] Item is not required
Data type
text
Alias
- UMLS CUI [1]
- C2826302
Description
[hidden]
Data type
text
Alias
- UMLS CUI [1]
- C1140263
Description
[hidden]
Data type
text
Alias
- UMLS CUI [1]
- C2347090
Description
[hidden]
Data type
text
Alias
- UMLS CUI [1,1]
- C0805701
- UMLS CUI [1,2]
- C0231175
Description
Status
Data type
integer
Alias
- UMLS CUI [1]
- C0449438
Description
Other medical conditions
Description
Drug Allergies
Data type
integer
Alias
- UMLS CUI [1]
- C0013182
Description
Rheumatoid Arthritis
Data type
integer
Alias
- UMLS CUI [1]
- C0003873
Description
Psoriasis
Data type
integer
Alias
- UMLS CUI [1]
- C0033860
Description
Thyroid Disease
Data type
integer
Alias
- UMLS CUI [1]
- C0040128
Description
Inflammatory Bowel Disease
Data type
integer
Alias
- UMLS CUI [1]
- C0021390
Description
Lupus
Data type
integer
Alias
- UMLS CUI [1]
- C0409974
Description
Sjogren's Syndrome
Data type
integer
Alias
- UMLS CUI [1]
- C1527336
Description
Vitiligo
Data type
integer
Alias
- UMLS CUI [1]
- C0042900
Similar models
Medical conditions (Liver MEDHX), Liver Event 5-DF
- StudyEvent: ODM
C0262926 (UMLS CUI-2)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0014644 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C3275124 (UMLS CUI [2])
(Comment:en)
(Comment:en)
(Comment:en)
C0277579 (UMLS CUI-2)
C0277579 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
(Comment:en)
C2348235 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
No comments